Logo image of QIPT

QUIPT HOME MEDICAL CORP (QIPT) Stock Fundamental Analysis

USA - NASDAQ:QIPT - CA74880P1045 - Common Stock

2.46 USD
+0.02 (+0.82%)
Last: 10/17/2025, 8:00:01 PM
Fundamental Rating

3

Taking everything into account, QIPT scores 3 out of 10 in our fundamental rating. QIPT was compared to 100 industry peers in the Health Care Providers & Services industry. QIPT may be in some trouble as it scores bad on both profitability and health. QIPT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year QIPT has reported negative net income.
In the past year QIPT had a positive cash flow from operations.
In the past 5 years QIPT reported 4 times negative net income.
QIPT had a positive operating cash flow in each of the past 5 years.
QIPT Yearly Net Income VS EBIT VS OCF VS FCFQIPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

QIPT's Return On Assets of -4.35% is on the low side compared to the rest of the industry. QIPT is outperformed by 67.00% of its industry peers.
QIPT's Return On Equity of -10.01% is in line compared to the rest of the industry. QIPT outperforms 42.00% of its industry peers.
Industry RankSector Rank
ROA -4.35%
ROE -10.01%
ROIC N/A
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)N/A
ROIC(5y)N/A
QIPT Yearly ROA, ROE, ROICQIPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

QIPT has a better Gross Margin (71.51%) than 87.00% of its industry peers.
In the last couple of years the Gross Margin of QIPT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for QIPT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 71.51%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
QIPT Yearly Profit, Operating, Gross MarginsQIPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

2

2. Health

2.1 Basic Checks

QIPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QIPT has more shares outstanding
The number of shares outstanding for QIPT has been increased compared to 5 years ago.
QIPT has a worse debt/assets ratio than last year.
QIPT Yearly Shares OutstandingQIPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
QIPT Yearly Total Debt VS Total AssetsQIPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

QIPT has an Altman-Z score of 0.37. This is a bad value and indicates that QIPT is not financially healthy and even has some risk of bankruptcy.
QIPT has a Altman-Z score of 0.37. This is in the lower half of the industry: QIPT underperforms 77.00% of its industry peers.
The Debt to FCF ratio of QIPT is 5.81, which is a neutral value as it means it would take QIPT, 5.81 years of fcf income to pay off all of its debts.
QIPT has a better Debt to FCF ratio (5.81) than 63.00% of its industry peers.
QIPT has a Debt/Equity ratio of 0.71. This is a neutral value indicating QIPT is somewhat dependend on debt financing.
The Debt to Equity ratio of QIPT (0.71) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 5.81
Altman-Z 0.37
ROIC/WACCN/A
WACC8.12%
QIPT Yearly LT Debt VS Equity VS FCFQIPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

A Current Ratio of 1.15 indicates that QIPT should not have too much problems paying its short term obligations.
QIPT has a worse Current ratio (1.15) than 66.00% of its industry peers.
A Quick Ratio of 0.75 indicates that QIPT may have some problems paying its short term obligations.
QIPT has a Quick ratio of 0.75. This is amonst the worse of the industry: QIPT underperforms 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 0.75
QIPT Yearly Current Assets VS Current LiabilitesQIPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for QIPT have decreased strongly by -90.91% in the last year.
The Revenue for QIPT has decreased by -10.21% in the past year. This is quite bad
The Revenue has been growing by 32.16% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
Revenue 1Y (TTM)-10.21%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-8.88%

3.2 Future

Based on estimates for the next years, QIPT will show a very strong growth in Earnings Per Share. The EPS will grow by 97.77% on average per year.
The Revenue is expected to grow by 21.85% on average over the next years. This is a very strong growth
EPS Next Y-64.33%
EPS Next 2Y23.79%
EPS Next 3Y2.12%
EPS Next 5Y97.77%
Revenue Next Year-7.25%
Revenue Next 2Y9.25%
Revenue Next 3Y6.7%
Revenue Next 5Y21.85%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
QIPT Yearly Revenue VS EstimatesQIPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
QIPT Yearly EPS VS EstimatesQIPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QIPT. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QIPT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QIPT Price Earnings VS Forward Price EarningsQIPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, QIPT is valued cheaply inside the industry as 91.00% of the companies are valued more expensively.
94.00% of the companies in the same industry are more expensive than QIPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 6.72
EV/EBITDA 5.13
QIPT Per share dataQIPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.79%
EPS Next 3Y2.12%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QIPT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUIPT HOME MEDICAL CORP

NASDAQ:QIPT (10/17/2025, 8:00:01 PM)

2.46

+0.02 (+0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)08-11 2025-08-11/amc
Earnings (Next)12-15 2025-12-15/amc
Inst Owners47.08%
Inst Owner Change0%
Ins Owners15.18%
Ins Owner Change0%
Market Cap106.86M
Analysts80
Price Target3.75 (52.44%)
Short Float %2.42%
Short Ratio1.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.85%
Min Revenue beat(2)-9.06%
Max Revenue beat(2)-0.65%
Revenue beat(4)0
Avg Revenue beat(4)-8.24%
Min Revenue beat(4)-20.53%
Max Revenue beat(4)-0.65%
Revenue beat(8)0
Avg Revenue beat(8)-5.71%
Revenue beat(12)1
Avg Revenue beat(12)-4.96%
Revenue beat(16)2
Avg Revenue beat(16)-4.19%
PT rev (1m)0.59%
PT rev (3m)-28.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)44.45%
EPS NY rev (1m)-7.41%
EPS NY rev (3m)-141.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.8%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.47
P/FCF 6.72
P/OCF 3.57
P/B 1.04
P/tB N/A
EV/EBITDA 5.13
EPS(TTM)-0.21
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)0.37
FCFY14.89%
OCF(TTM)0.69
OCFY27.98%
SpS5.29
BVpS2.36
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.35%
ROE -10.01%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 71.51%
FCFM 6.93%
ROA(3y)-0.08%
ROA(5y)-2.47%
ROE(3y)-0.93%
ROE(5y)-5.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.22%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.23%
GM growth 5Y-0.04%
F-Score3
Asset Turnover0.97
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 5.81
Debt/EBITDA 2
Cap/Depr 33.78%
Cap/Sales 6.09%
Interest Coverage N/A
Cash Conversion 81.97%
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 0.75
Altman-Z 0.37
F-Score3
WACC8.12%
ROIC/WACCN/A
Cap/Depr(3y)26.65%
Cap/Depr(5y)21.79%
Cap/Sales(3y)4.61%
Cap/Sales(5y)3.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-90.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-75%
EPS Next Y-64.33%
EPS Next 2Y23.79%
EPS Next 3Y2.12%
EPS Next 5Y97.77%
Revenue 1Y (TTM)-10.21%
Revenue growth 3Y33.91%
Revenue growth 5Y32.16%
Sales Q2Q%-8.88%
Revenue Next Year-7.25%
Revenue Next 2Y9.25%
Revenue Next 3Y6.7%
Revenue Next 5Y21.85%
EBIT growth 1Y-209.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1642.71%
EBIT Next 3Y181.71%
EBIT Next 5Y154.85%
FCF growth 1Y-39.09%
FCF growth 3Y22.49%
FCF growth 5Y24.98%
OCF growth 1Y-12.62%
OCF growth 3Y23.7%
OCF growth 5Y33.42%